title: Double-phase parathyroid scintigraphy in dogs using technetium-99M-sestamibi.
abstract: The purpose of this study was to evaluate the utility of double-phase parathyroid scintigraphy using 99mTc-sestamibi for detecting and localizing hyperfunctioning parathyroid glands in hypercalcemic dogs. Fifteen hypercalcemic dogs that underwent parathyroid scintigraphy were included in this study: 3 dogs with hypercalcemia of malignancy, and 12 dogs with hyperfunctioning parathyroid tissue (parathyroid adenoma or parathyroid hyperplasia). The presence of parathyroid adenoma or parathyroid hyperplasia was documented by histopathologic examination. In 3 dogs with hypercalcemia of malignancy, parathyroid scintigraphy was negative for hyperfunctioning parathyroid tissue and the scans were classified as true negative. Parathyroid scintigraphy correctly identified the presence and location of hyperfunctioning parathyroid tissue in only 1 of 6 dogs with a parathyroid adenoma. False positive and false negative results occurred in dogs with parathyroid adenomas. Parathyroid scintigraphy failed to detect hyperfunctioning parathyroid tissue in 5 of 6 dogs with parathyroid hyperplasia and were classified as false negative. False positive results were obtained in the remaining dog with parathyroid hyperplasia. Sensitivity of parathyroid scintigraphy for detecting and localizing hyperfunctioning parathyroid tissue was 11%, specificity was 50%, and overall accuracy was 27%. Positive and negative predictive value were 25% and 27%, respectively. Sensitivity for detection of parathyroid adenomas was 25%, and sensitivity for detection of hyperplastic glands was 0 %. Results of this study indicate that double-phase parathyroid scintigraphy does not appear to have acceptable accuracy in detecting hyperfunctioning parathyroid glands in dogs. Due to the poor sensitivity and specificity of the technique in dogs, parathyroid scintigraphy is not recommended for definitive identification of abnormal parathyroid glands as the cause of hypercalcemia in dogs.
authors.affiliation: Department of Veterinary Internal Medicine, Western College of Veterinary Medicine, Royal University Hospital, University of Saskatchewan, Saskatoon, Canada.
authors.forename: C L
authors.initials: CL
authors.lastname: Matwichuk
authors.forename: S M
authors.initials: SM
authors.lastname: Taylor
authors.forename: G B
authors.initials: GB
authors.lastname: Daniel
authors.forename: A A
authors.initials: AA
authors.lastname: Wilkinson
authors.forename: G G
authors.initials: GG
authors.lastname: Matte
authors.forename: E M
authors.initials: EM
authors.lastname: Dudzic
authors.forename: C L
authors.initials: CL
authors.lastname: Shmon
mesh_terms: D000818:Animals; D004283:Dog Diseases / Q000000981:diagnostic imaging*; D004285:Dogs; D005188:False Negative Reactions; D005189:False Positive Reactions; D010279:Parathyroid Diseases / Q000000981:diagnostic imaging / Q000662:veterinary*; D011877:Radionuclide Imaging / Q000379:methods*; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi
chemical_list: D017256:Technetium Tc 99m Sestamibi